Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tekturna in early atherosclerosis
NCT01067326Phase 3Terminated
- Sponsor
- Mayo Clinic
- Start
- Feb 2010
- Primary completion
- Dec 2011
- Countries
- 1
01
Overview
A Phase 3 trial of aliskiren in endothelial dysfunction, sponsored by Mayo Clinic. Started Feb 2010; status: terminated.
02
Drugs
aliskiren
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NCT01067326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067326.